- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05859360
Functional Exercise Training in Cerebral Palsy: Follow Up (FITCP)
Functional Exercise Training With Adolescents and Young Adults With Cerebral Palsy: Follow Up Study
The goal of this cross-sectional study is to compare able-bodied peers to adolescents and young adults with cerebral palsy (CP) who have been regularly performing high-intensity functional training for almost two years.
The main research question is: is structured, long-term exercise training able to compensate strength and cardiovascular deficits in adolescents with CP compared to able-bodied peers?
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Basel-Stadt
-
Basel, Basel-Stadt, Switzerland, 4052
- Department of Sport, Exercise and Health, University of Basel
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
CP Individuals:
- Diagnosis of CP.
- Between 14 and 26 years of age.
- Gross Motor Functional Classification System (GMFCS): I-II.
- Cognitive abilities must include: Ability to verbally or non-verbally communicate pain or discomfort; Ability to attend testing and; ability to understand and follow instructions. All included participants are capable of making decisions on their own and no not show any signs of mental or cognitive limitations.
Healthy peers:
- Between 14 and 26 years of age.
Exclusion Criteria:
CP Individuals:
- Any surgery or botulinum toxin treatment within 6 months prior to the measurements or scheduled during study period. Other medications can be continued as prescribed by the participants' physician.
- Known cardiovascular or pulmonary diseases that have not received medical clearance to participate in physical exercise.
- Uncontrolled seizures or epilepsy.
- Inability to conform to the above mentioned cognitive and physical abilities.
Healthy peers:
- Diagnosis of congenital heart defects, pulmonary diseases or any neuromuscular disorders or diseases.
- Diagnosis of any acute diseases.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Trained CP
Adolescents and young adults with CP who have continued their regular training after completing the pilot study.
|
|
|
Untrained CP
Adolescents and young adults with CP who have not continued their regular training after completing the pilot study.
|
|
|
Trained Peers
Healthy peers who perform high-intensity strength training on a regular basis.
|
|
|
Untrained Peers
Healthy peers who do not perform high-intensity strength training on a regular basis.
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maximum knee extension force
Time Frame: 20 minutes
|
Maximum force of knee extension in relation to body weight
|
20 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Microvascular health
Time Frame: 5 minutes
|
Static retinal vessel analysis
|
5 minutes
|
|
Voluntary activation
Time Frame: 15 minutes
|
Maximum force able to voluntarily activate
|
15 minutes
|
|
Spiroergometry
Time Frame: 20 minutes
|
Cardiopulmonary test on bicycle ergometer
|
20 minutes
|
|
Muscle architecture
Time Frame: 10 minutes
|
Ultrasound of defined muscle groups
|
10 minutes
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FITCP: Follow Up
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.